| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smoking | 20 | 2023 | 2538 | 2.170 |
Why?
|
| Genome-Wide Association Study | 23 | 2023 | 2333 | 1.990 |
Why?
|
| Scleroderma, Systemic | 12 | 2019 | 164 | 1.910 |
Why?
|
| Lung Neoplasms | 36 | 2024 | 12012 | 1.800 |
Why?
|
| Genetic Predisposition to Disease | 31 | 2023 | 5750 | 1.560 |
Why?
|
| Polymorphism, Single Nucleotide | 28 | 2023 | 4639 | 1.300 |
Why?
|
| Codon, Nonsense | 3 | 2022 | 160 | 0.970 |
Why?
|
| Tobacco Smoke Pollution | 3 | 2011 | 112 | 0.620 |
Why?
|
| Genome, Human | 10 | 2020 | 1885 | 0.620 |
Why?
|
| Volatile Organic Compounds | 1 | 2017 | 13 | 0.600 |
Why?
|
| Genetic Variation | 6 | 2020 | 2156 | 0.600 |
Why?
|
| Breath Tests | 1 | 2017 | 201 | 0.570 |
Why?
|
| Quantitative Trait Loci | 6 | 2022 | 381 | 0.530 |
Why?
|
| Genomic Imprinting | 3 | 2007 | 200 | 0.520 |
Why?
|
| Models, Biological | 3 | 2011 | 3223 | 0.520 |
Why?
|
| Mutation, Missense | 10 | 2024 | 1197 | 0.490 |
Why?
|
| Diet | 2 | 2013 | 1489 | 0.460 |
Why?
|
| Genetic Linkage | 4 | 2007 | 601 | 0.450 |
Why?
|
| Case-Control Studies | 19 | 2020 | 6236 | 0.450 |
Why?
|
| Early Detection of Cancer | 3 | 2017 | 1340 | 0.440 |
Why?
|
| Models, Statistical | 7 | 2019 | 1190 | 0.440 |
Why?
|
| Betaine | 1 | 2013 | 25 | 0.430 |
Why?
|
| Models, Genetic | 4 | 2008 | 1168 | 0.430 |
Why?
|
| Gene Frequency | 7 | 2022 | 1241 | 0.420 |
Why?
|
| DNA Repair | 3 | 2012 | 1912 | 0.420 |
Why?
|
| Introns | 1 | 2014 | 461 | 0.420 |
Why?
|
| Choline | 1 | 2013 | 74 | 0.420 |
Why?
|
| Selection, Genetic | 3 | 2024 | 198 | 0.410 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 6 | 2023 | 5566 | 0.410 |
Why?
|
| Alleles | 6 | 2020 | 2599 | 0.390 |
Why?
|
| Neoplasm Proteins | 4 | 2018 | 3363 | 0.390 |
Why?
|
| Sex Factors | 4 | 2011 | 2206 | 0.390 |
Why?
|
| Risk Factors | 23 | 2023 | 18045 | 0.370 |
Why?
|
| Carcinogenesis | 1 | 2017 | 1037 | 0.360 |
Why?
|
| Receptors, Nicotinic | 1 | 2011 | 202 | 0.350 |
Why?
|
| Models, Theoretical | 1 | 2014 | 809 | 0.340 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 869 | 0.340 |
Why?
|
| Multivariate Analysis | 4 | 2022 | 4352 | 0.340 |
Why?
|
| Humans | 74 | 2024 | 271884 | 0.330 |
Why?
|
| Odds Ratio | 6 | 2022 | 2335 | 0.330 |
Why?
|
| Logistic Models | 8 | 2022 | 3469 | 0.320 |
Why?
|
| Genetic Loci | 4 | 2016 | 497 | 0.310 |
Why?
|
| Biological Evolution | 4 | 2015 | 292 | 0.310 |
Why?
|
| Body Size | 1 | 2007 | 69 | 0.290 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2007 | 233 | 0.270 |
Why?
|
| Male | 39 | 2023 | 128957 | 0.260 |
Why?
|
| Feeding Behavior | 1 | 2011 | 824 | 0.250 |
Why?
|
| Genes, Neoplasm | 2 | 2019 | 317 | 0.240 |
Why?
|
| Middle Aged | 27 | 2020 | 90395 | 0.240 |
Why?
|
| Neoplasms | 8 | 2020 | 15915 | 0.230 |
Why?
|
| Receptors, Interleukin-12 | 2 | 2014 | 13 | 0.230 |
Why?
|
| Data Interpretation, Statistical | 2 | 2005 | 486 | 0.220 |
Why?
|
| Research Design | 1 | 2011 | 1580 | 0.220 |
Why?
|
| Female | 35 | 2023 | 149143 | 0.220 |
Why?
|
| Interferon Regulatory Factors | 2 | 2014 | 75 | 0.220 |
Why?
|
| Family | 1 | 2007 | 778 | 0.210 |
Why?
|
| Genetic Association Studies | 2 | 2022 | 1095 | 0.210 |
Why?
|
| Aged | 21 | 2020 | 73471 | 0.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2023 | 9099 | 0.210 |
Why?
|
| RNA Splicing | 3 | 2014 | 362 | 0.200 |
Why?
|
| Nucleotides | 1 | 2022 | 175 | 0.200 |
Why?
|
| Oncogenes | 2 | 2022 | 701 | 0.200 |
Why?
|
| Frameshift Mutation | 2 | 2019 | 235 | 0.190 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2014 | 266 | 0.190 |
Why?
|
| Conserved Sequence | 1 | 2022 | 499 | 0.180 |
Why?
|
| Exons | 3 | 2014 | 1388 | 0.180 |
Why?
|
| Software | 1 | 2007 | 1385 | 0.170 |
Why?
|
| Venous Thrombosis | 1 | 2023 | 381 | 0.170 |
Why?
|
| Gene Expression Profiling | 5 | 2019 | 5186 | 0.160 |
Why?
|
| Computer Simulation | 5 | 2014 | 1572 | 0.160 |
Why?
|
| Prostatic Neoplasms | 5 | 2017 | 5996 | 0.160 |
Why?
|
| Cohort Studies | 8 | 2023 | 9491 | 0.150 |
Why?
|
| Octanes | 1 | 2017 | 1 | 0.150 |
Why?
|
| Germ-Line Mutation | 2 | 2020 | 1102 | 0.150 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 376 | 0.150 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2020 | 437 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2019 | 274 | 0.150 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2017 | 94 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2018 | 227 | 0.150 |
Why?
|
| Furans | 1 | 2017 | 103 | 0.140 |
Why?
|
| Obesity | 2 | 2007 | 2958 | 0.140 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2017 | 46 | 0.140 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 6210 | 0.140 |
Why?
|
| Genotype | 8 | 2018 | 4265 | 0.140 |
Why?
|
| Mutation | 4 | 2024 | 15924 | 0.140 |
Why?
|
| Body Mass Index | 2 | 2005 | 2258 | 0.140 |
Why?
|
| Idiopathic Interstitial Pneumonias | 1 | 2016 | 13 | 0.130 |
Why?
|
| Computational Biology | 3 | 2015 | 1281 | 0.130 |
Why?
|
| Rhinitis, Allergic, Seasonal | 2 | 2006 | 28 | 0.130 |
Why?
|
| Telomerase | 1 | 2019 | 543 | 0.130 |
Why?
|
| Adult | 15 | 2023 | 81857 | 0.130 |
Why?
|
| Tumor Burden | 2 | 2012 | 2035 | 0.130 |
Why?
|
| Age Factors | 4 | 2011 | 5520 | 0.120 |
Why?
|
| Blood | 1 | 2015 | 172 | 0.120 |
Why?
|
| Age of Onset | 3 | 2012 | 852 | 0.120 |
Why?
|
| Skin Neoplasms | 2 | 2023 | 4889 | 0.120 |
Why?
|
| Risk | 3 | 2020 | 1950 | 0.120 |
Why?
|
| CpG Islands | 4 | 2023 | 662 | 0.120 |
Why?
|
| Pedigree | 3 | 2020 | 2036 | 0.120 |
Why?
|
| beta Karyopherins | 1 | 2014 | 34 | 0.120 |
Why?
|
| Linkage Disequilibrium | 2 | 2014 | 495 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2020 | 2496 | 0.120 |
Why?
|
| Melanoma | 2 | 2023 | 5592 | 0.120 |
Why?
|
| Surveys and Questionnaires | 4 | 2020 | 5928 | 0.110 |
Why?
|
| Likelihood Functions | 2 | 2005 | 239 | 0.110 |
Why?
|
| Genomics | 3 | 2014 | 2830 | 0.110 |
Why?
|
| rhoB GTP-Binding Protein | 1 | 2012 | 7 | 0.110 |
Why?
|
| DNA-Binding Proteins | 5 | 2022 | 5066 | 0.110 |
Why?
|
| Environmental Exposure | 1 | 2015 | 288 | 0.110 |
Why?
|
| Neoplasm Staging | 3 | 2014 | 13993 | 0.110 |
Why?
|
| Prognosis | 5 | 2023 | 22537 | 0.100 |
Why?
|
| Glioblastoma | 1 | 2023 | 1781 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2014 | 325 | 0.100 |
Why?
|
| Aged, 80 and over | 9 | 2020 | 31042 | 0.100 |
Why?
|
| Europe | 4 | 2019 | 659 | 0.100 |
Why?
|
| HLA Antigens | 2 | 2014 | 588 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2014 | 413 | 0.100 |
Why?
|
| Food, Organic | 1 | 2011 | 3 | 0.100 |
Why?
|
| Cocarcinogenesis | 1 | 2011 | 56 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2003 | 257 | 0.100 |
Why?
|
| Diet, Fat-Restricted | 1 | 2011 | 53 | 0.100 |
Why?
|
| Selection Bias | 1 | 2011 | 48 | 0.100 |
Why?
|
| Autoantibodies | 2 | 2011 | 600 | 0.090 |
Why?
|
| Vitamin A | 1 | 2011 | 91 | 0.090 |
Why?
|
| Eligibility Determination | 1 | 2011 | 85 | 0.090 |
Why?
|
| Genes, p53 | 2 | 2005 | 1146 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2024 | 5603 | 0.090 |
Why?
|
| Genetic Markers | 2 | 2011 | 1076 | 0.090 |
Why?
|
| Carotenoids | 1 | 2011 | 102 | 0.090 |
Why?
|
| SEER Program | 1 | 2014 | 1047 | 0.090 |
Why?
|
| Interviews as Topic | 1 | 2011 | 520 | 0.080 |
Why?
|
| Registries | 3 | 2012 | 2250 | 0.080 |
Why?
|
| Lung | 2 | 2023 | 3294 | 0.080 |
Why?
|
| Fruit | 1 | 2011 | 302 | 0.080 |
Why?
|
| Genotyping Techniques | 2 | 2020 | 163 | 0.080 |
Why?
|
| CD3 Complex | 1 | 2010 | 321 | 0.080 |
Why?
|
| Databases, Nucleic Acid | 2 | 2008 | 116 | 0.080 |
Why?
|
| Vegetables | 1 | 2011 | 330 | 0.080 |
Why?
|
| Disease | 1 | 2010 | 165 | 0.080 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 1443 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2011 | 7790 | 0.080 |
Why?
|
| Energy Intake | 1 | 2011 | 525 | 0.080 |
Why?
|
| Forecasting | 1 | 2011 | 706 | 0.080 |
Why?
|
| Phenotype | 5 | 2012 | 6515 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2019 | 2974 | 0.080 |
Why?
|
| Asthma | 2 | 2006 | 894 | 0.070 |
Why?
|
| DNA Breaks | 1 | 2007 | 38 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 1295 | 0.070 |
Why?
|
| Motor Activity | 1 | 2011 | 718 | 0.070 |
Why?
|
| Texas | 3 | 2013 | 6435 | 0.070 |
Why?
|
| Confidence Intervals | 1 | 2008 | 758 | 0.070 |
Why?
|
| Mutagens | 1 | 2007 | 192 | 0.070 |
Why?
|
| Dust | 1 | 2006 | 41 | 0.070 |
Why?
|
| Organ Specificity | 2 | 2019 | 754 | 0.070 |
Why?
|
| Epidemiologic Studies | 1 | 2006 | 57 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 995 | 0.070 |
Why?
|
| Genetics, Population | 2 | 2008 | 258 | 0.070 |
Why?
|
| Age Distribution | 1 | 2007 | 730 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 1598 | 0.060 |
Why?
|
| DNA Mutational Analysis | 1 | 2011 | 2365 | 0.060 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 340 | 0.060 |
Why?
|
| Proteins | 1 | 2012 | 2058 | 0.060 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2003 | 18 | 0.060 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 16241 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2007 | 1588 | 0.060 |
Why?
|
| Nuclear Proteins | 2 | 2013 | 3472 | 0.060 |
Why?
|
| Adenocarcinoma | 2 | 2020 | 7975 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2003 | 64 | 0.050 |
Why?
|
| Body Constitution | 1 | 2002 | 39 | 0.050 |
Why?
|
| DNA Methylation | 2 | 2023 | 2761 | 0.050 |
Why?
|
| Minisatellite Repeats | 1 | 2002 | 66 | 0.050 |
Why?
|
| Radiography, Thoracic | 1 | 2005 | 474 | 0.050 |
Why?
|
| Disease Progression | 1 | 2014 | 6909 | 0.050 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2002 | 126 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2004 | 504 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2002 | 189 | 0.050 |
Why?
|
| Sample Size | 1 | 2002 | 215 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2023 | 3262 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 323 | 0.050 |
Why?
|
| Multifactorial Inheritance | 1 | 2002 | 163 | 0.050 |
Why?
|
| Lung Diseases | 1 | 2007 | 755 | 0.050 |
Why?
|
| Early Diagnosis | 1 | 2003 | 316 | 0.050 |
Why?
|
| Inflammation | 1 | 2011 | 2533 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 6270 | 0.050 |
Why?
|
| Biomarkers, Tumor | 3 | 2024 | 10750 | 0.050 |
Why?
|
| Siblings | 1 | 2002 | 307 | 0.050 |
Why?
|
| Silent Mutation | 1 | 2020 | 3 | 0.050 |
Why?
|
| Haplotypes | 2 | 2014 | 909 | 0.050 |
Why?
|
| Jews | 1 | 2020 | 57 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2014 | 2624 | 0.040 |
Why?
|
| Open Reading Frames | 2 | 2014 | 275 | 0.040 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2019 | 44 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 4998 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2002 | 668 | 0.040 |
Why?
|
| Monte Carlo Method | 1 | 2003 | 704 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2009 | 6883 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2018 | 79 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2020 | 591 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 155 | 0.040 |
Why?
|
| Mutation Rate | 1 | 2018 | 220 | 0.040 |
Why?
|
| Child | 3 | 2018 | 30492 | 0.040 |
Why?
|
| Mucins | 1 | 2019 | 289 | 0.040 |
Why?
|
| Biomarkers | 2 | 2023 | 5112 | 0.040 |
Why?
|
| Gene-Environment Interaction | 1 | 2018 | 163 | 0.040 |
Why?
|
| Heterozygote | 1 | 2020 | 1057 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 1136 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2020 | 751 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 1025 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 1439 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2023 | 2034 | 0.030 |
Why?
|
| Linear Models | 1 | 2019 | 1100 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2018 | 16999 | 0.030 |
Why?
|
| Algorithms | 3 | 2012 | 3923 | 0.030 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2014 | 10 | 0.030 |
Why?
|
| Microchip Analytical Procedures | 1 | 2014 | 9 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 681 | 0.030 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2014 | 41 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2009 | 13400 | 0.030 |
Why?
|
| Endodeoxyribonucleases | 1 | 2014 | 115 | 0.030 |
Why?
|
| Mass Screening | 2 | 2012 | 1547 | 0.030 |
Why?
|
| Co-Repressor Proteins | 1 | 2013 | 120 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 3022 | 0.020 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 263 | 0.020 |
Why?
|
| Vital Capacity | 1 | 2012 | 139 | 0.020 |
Why?
|
| Airway Remodeling | 1 | 2011 | 28 | 0.020 |
Why?
|
| Life Style | 1 | 2015 | 622 | 0.020 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2011 | 58 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2011 | 48 | 0.020 |
Why?
|
| Activin Receptors, Type I | 1 | 2011 | 58 | 0.020 |
Why?
|
| Calibration | 1 | 2012 | 346 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 4399 | 0.020 |
Why?
|
| Carrier Proteins | 2 | 2014 | 2139 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 532 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2012 | 502 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2014 | 433 | 0.020 |
Why?
|
| Young Adult | 2 | 2020 | 22108 | 0.020 |
Why?
|
| Adolescent | 2 | 2018 | 32663 | 0.020 |
Why?
|
| United States | 3 | 2012 | 16050 | 0.020 |
Why?
|
| Mortality | 1 | 2012 | 354 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2011 | 33863 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2014 | 1053 | 0.020 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2012 | 215 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2013 | 911 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2002 | 2307 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2012 | 39780 | 0.020 |
Why?
|
| Genes, Overlapping | 1 | 2008 | 15 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 4199 | 0.020 |
Why?
|
| 5' Untranslated Regions | 1 | 2008 | 99 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2019 | 9325 | 0.020 |
Why?
|
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 1 | 2007 | 96 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2008 | 339 | 0.020 |
Why?
|
| Family Health | 1 | 2007 | 348 | 0.020 |
Why?
|
| Bleomycin | 1 | 2007 | 482 | 0.020 |
Why?
|
| Comorbidity | 1 | 2012 | 2439 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2018 | 8602 | 0.020 |
Why?
|
| Lod Score | 1 | 2005 | 169 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2005 | 148 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2005 | 142 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2005 | 196 | 0.010 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2003 | 206 | 0.010 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2003 | 179 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 13931 | 0.010 |
Why?
|
| Incidence | 1 | 2012 | 5861 | 0.010 |
Why?
|
| Mice | 1 | 2023 | 36041 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2005 | 735 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 5330 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 3417 | 0.010 |
Why?
|
| Survival Rate | 1 | 2012 | 12533 | 0.010 |
Why?
|
| Animals | 1 | 2023 | 62807 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2010 | 2668 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2003 | 1482 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 15267 | 0.010 |
Why?
|